期刊
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
卷 12, 期 3, 页码 365-368出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00042737-200012030-00017
关键词
amoxycillin-clavulanate potassium; intra-hepatic cholestasis; ursodeoxycholic acid
This report describes two patients who developed jaundice within two weeks of receiving an amoxycillin - clavulanate potassium combination. Causes of jaundice, other than drug administration, were excluded. The patients' jaundice and clinical symptoms did not respond to stopping the drug. Ursodeoxycholic acid (750 mg/day) led to a prompt and sustained improvement in their hyperbilirubinaemia and symptoms such as pruritus and fatigue. These cases suggest that ursodeoxycholic acid may be an effective treatment for drug-associated cholestasis, Eur J Gastroenterol Hepatol 12:365 - 368 (C) 2000 Lippincott Williams & Wilkins.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据